Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

ESC 2021 | TOMAHAWK: Angiography After Resuscitated Patients from Out-Of-Hospital Cardiac Arrest with No ST Elevation.

What triggered this study was a long unanswered question: should patients successfully resuscitated from an out-of-hospital cardiac arrest presenting a non-STEMI ECG be immediately taken to the cath lab? 

ESC 2021 | TOMAHAWK: Angiografía luego de un paro cardíaco reanimado y sin supradesnivel del ST

In response to this question the TOMAHAWK randomized 554 out-of-hospital resuscitated patients without electrocardiographic evidence of ST-segment elevation patients to immediate angiography (n=281) vs intensive care assessment for elective or delayed angiography (n=273).

Finally, for protocol reasons, 265 patients of each arm were analyzed. 

As a first finding, more than half of patients presented a defibrillating rhythm. Both arms required mean 15 minutes between cardiac arrest and return of spontaneous circulation 

Most patients in both arms had coronary lesions in one vessel. 38.1% in the immediate angiography arm vs. 43% in the elective angiography group had a clear culprit lesion. They all received an angiography in both arms. 

At 30 days, observed mortality was 54% in the immediate angiography group vs 46% in the delayed or elective angiography group. This difference was not statistically significative both by protocol analysis and by treatment. 

Most patients in both arms died from cerebral anoxia or circulatory collapse. 


Read also: ESC 2021 | MASTER DAPT: Dual Antiplatelet Therapy After Coronary Angioplasty in Patients at High Bleeding Risk.


There were several secondary end points to look at, though with the same result. Severe neurological deficit resulted similar between the groups, as did all safety end points such as bleeding, stroke or kidney injury. This suggests an early angiography holds neither benefits nor harm. Only when looking at the combination of death and severe neurological deficit do we see a higher incidence in the immediate angiography group (64.3% vs 55.6%, RR 1.16, CI 95% 1 to 1.34). This difference is barely reaching statistical significance. 

Roughly 40% of patients in the TOMAHAWK presented a culprit coronary lesion, but even in these cases, the neurological damage produced during cardiac attest was what sealed patient destiny. 

The outcomes of this study can be classified as neutral, even though its real value lies on patient management at arrival, after resuscitation, and with no ST elevation ECG reading. It seems prudent to take time to rule out other causes of cardiac arrest, count on a lab, etc. 

The TOMAHAWK supports the prior COACT outcomes, which had shown similar results at 90 days and a year.  

Original Title: Angiography after out-of-hospital cardiac arrest without ST-segment elevation.

Reference: Desch S et al. Presentado en el ESC el 29 de agosto 2021 y publicado simultáneamente en NEJM.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...